The company's shares boosted 2% in early Tuesday trade after announcing the deal, sparked by fears based on three human cases of H5N1 virus infections since March and an outbreak among cows.
Scientists are apparently concerned the virus could mutate and spark another pandemic.
While Big Pharma is concerned that a lack of public pandemic panic is hurting their profit margins?
Post a Comment
Let know your opinion on this story